Sartorius Stedim Biotech S.A.

SRTOY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$75,021$92,600$115,400$40,900
Dep. & Amort.$92,198$77,900$77,400$80,600
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$4,042-$56,900-$34,700$138,500
Other Non-Cash-$93,894$11,300-$38,300$24,900
Operating Cash Flow$77,367$124,900$119,800$284,900
Investing Activities
PP&E Inv.-$157,579-$75,900-$65,300-$80,000
Net Acquisitions$1,087-$1,000$0$0
Inv. Purchases-$3,155$0$0-$100
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$100
Investing Cash Flow-$159,647-$76,900-$65,300-$80,200
Financing Activities
Debt Repay.-$361,944$12,900-$13,700-$5,400
Stock Issued$0$0$0$2,200
Stock Repurch.-$3,529$1,100-$2,000$600
Dividends Paid-$2,652-$67,100$0$0
Other Fin. Act.$73-$200-$9,900-$8,800
Financing Cash Flow-$368,052-$53,300-$25,600-$11,400
Forex Effect-$19,569-$3,000-$300$3,100
Net Chg. in Cash-$469,901-$8,300$28,700$196,300
Supplemental Information
Beg. Cash$820,873$707,600$678,900$482,600
End Cash$350,973$699,300$707,600$678,900
Free Cash Flow-$80,212$49,000$54,500$204,900